Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Essential Pharma Announces the Acquisition of HALDOL
Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access […]
Touchlight and Odimma Therapeutics Announce Clinical Material Supply Agreement to Develop Personalised Cancer Therapy Utilising Doggybone DNA
Touchlight, a biotechnology company pioneering enzymatic DNA production to enable genetic medicines, has announced a […]
Enthea Announces Nationwide Rollout to Offer Psychedelic Therapy as a Workplace Benefit
Enthea, the first provider of insurance plans for psychedelic healthcare, announces its successful $2M seed […]
Medikine Appoints Roland Buelow, Ph.D., to Board of Directors
Medikine, a clinical-stage biopharmaceutical company developing transformative therapeutics for cancer, autoimmune disorders, and infectious diseases […]
PacBio and Boston Children's Hospital Collaborate to Investigate Novel Variants Inaccessible by Short-Read Sequencing
PacBio, a leading developer of high-quality, highly accurate sequencing solutions, has announced its HiFi sequencing […]
AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Immunology Pipeline
AbbVie and HotSpot Therapeutics, a biotechnology company pioneering the discovery and development of small molecule […]
Caris Life Sciences and Hummingbird Bioscience Enter Into Collaboration to Advance Clinical Development of Anti-HER3 Therapy
Caris Life Sciences®, the leading molecular science and technology company actively developing and delivering innovative […]
Medical Mutual Finalizes Acquisition of Reserve National Insurance Company
On Dec. 1, 2022, Medical Mutual closed on the acquisition of Reserve National Insurance Company, […]
Carle Health Partners with Health Catalyst to Achieve Data-Informed Improvement
Health Catalyst, a leading provider of data and analytics technology and services to healthcare organizations, […]
NRx Pharmaceuticals Appoints Carrie M. Carretta as Senior Vice President of Clinical Development and Medical Affairs
NRx Pharmaceuticals, a clinical-stage central nervous system (CNS) biopharmaceutical company, has announced the appointment of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more